Akebia Therapeutics (AKBA) Restructuring Costs (2022 - 2024)

Akebia Therapeutics (AKBA) has 3 years of Restructuring Costs data on file, last reported at $58000.0 in Q1 2024.

• Restructuring Costs for Q1 2024 came in at $58000.0, down 45.28% year-over-year; the trailing twelve-month figure through Dec 2024 was $58000.0 (down 67.96% YoY), and the FY2024 annual result was $58000.0, down 67.96% from the prior year.
• Restructuring Costs fell to $58000.0 in Q1 2024 per AKBA's latest filing, from $169000.0 in the prior quarter.
• Over five years, Restructuring Costs peaked at $14.5 million in Q2 2022 and troughed at -$94000.0 in Q2 2023.
• A 3-year average of $2.3 million and a median of $169000.0 in 2023 frame the typical range for Restructuring Costs.
• On a YoY basis, Restructuring Costs climbed as much as 6.11% in 2023 and fell as far as 100.65% in 2023.
• A 3-year view of Restructuring Costs shows it stood at $1.2 million in 2022, then tumbled by 86.17% to $169000.0 in 2023, then plunged by 65.68% to $58000.0 in 2024.
• Business Quant data shows AKBA's Restructuring Costs at $58000.0 in Q1 2024, $169000.0 in Q3 2023, and -$94000.0 in Q2 2023.